Cargando…

SPEN, a new player in primary cilia formation and cell migration in breast cancer

BACKGROUND: The primary cilium is a microtubule-based and nonmotile organelle functioning as a cellular antenna that is involved in the regulation of cell proliferation, differentiation, and migration. In breast cancer cells, the primary cilium is a structure that decreases in incidence with increas...

Descripción completa

Detalles Bibliográficos
Autores principales: Légaré, Stéphanie, Chabot, Catherine, Basik, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588740/
https://www.ncbi.nlm.nih.gov/pubmed/28877752
http://dx.doi.org/10.1186/s13058-017-0897-3
_version_ 1783262231728750592
author Légaré, Stéphanie
Chabot, Catherine
Basik, Mark
author_facet Légaré, Stéphanie
Chabot, Catherine
Basik, Mark
author_sort Légaré, Stéphanie
collection PubMed
description BACKGROUND: The primary cilium is a microtubule-based and nonmotile organelle functioning as a cellular antenna that is involved in the regulation of cell proliferation, differentiation, and migration. In breast cancer cells, the primary cilium is a structure that decreases in incidence with increasing degrees of transformation and may be biologically more important in estrogen receptor (ERα)-negative breast cancer cells. Split ends (SPEN) is an ERα corepressor that we have identified as a tumor suppressor protein in ERα-positive breast cancer cells whose hormone-independent roles in breast cancer have never been explored. METHODS: We determined the hormone-independent transcriptional program regulated by the ERα cofactor SPEN in breast cancer using DNA microarrays. The biological functions regulated by SPEN independently of hormones were studied in vitro in ERα-positive and ERα-negative breast cancer cells. Finally, we examined the clinical relevance of SPEN expression in cohorts of breast cancer samples with outcome data. RESULTS: We found that SPEN is coexpressed with a number of genes involved in ciliary biology, including the ciliogenic transcription factor RFX3, in a hormone-independent manner. SPEN reexpression in T47D cells containing a nonsense mutation in SPEN restored the primary cilium, whereas its knockdown in MCF10A and Hs578T cells considerably decreased primary cilia levels. We also report that SPEN regulates migration in breast cells, but only in those harboring primary cilia, and that KIF3A silencing, a critical factor in primary cilia, partially reverses SPEN’s effects, suggesting that SPEN may coordinate cellular movement through primary cilia-dependent mechanisms. Finally, we found that high SPEN RNA levels were predictive of early metastasis in two independent cohorts of 77 (HR 2.25, P = 0.03) and 170 (HR = 2.23, P = 0.004) patients with ERα-negative breast cancer. CONCLUSIONS: Together, our data demonstrate a role for SPEN in the regulation of primary cilia formation and cell migration in breast cancer cells, which may collectively explain why its expression is associated with time to metastasis in cohorts of patients with ERα-negative breast cancers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-017-0897-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5588740
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55887402017-09-14 SPEN, a new player in primary cilia formation and cell migration in breast cancer Légaré, Stéphanie Chabot, Catherine Basik, Mark Breast Cancer Res Research Article BACKGROUND: The primary cilium is a microtubule-based and nonmotile organelle functioning as a cellular antenna that is involved in the regulation of cell proliferation, differentiation, and migration. In breast cancer cells, the primary cilium is a structure that decreases in incidence with increasing degrees of transformation and may be biologically more important in estrogen receptor (ERα)-negative breast cancer cells. Split ends (SPEN) is an ERα corepressor that we have identified as a tumor suppressor protein in ERα-positive breast cancer cells whose hormone-independent roles in breast cancer have never been explored. METHODS: We determined the hormone-independent transcriptional program regulated by the ERα cofactor SPEN in breast cancer using DNA microarrays. The biological functions regulated by SPEN independently of hormones were studied in vitro in ERα-positive and ERα-negative breast cancer cells. Finally, we examined the clinical relevance of SPEN expression in cohorts of breast cancer samples with outcome data. RESULTS: We found that SPEN is coexpressed with a number of genes involved in ciliary biology, including the ciliogenic transcription factor RFX3, in a hormone-independent manner. SPEN reexpression in T47D cells containing a nonsense mutation in SPEN restored the primary cilium, whereas its knockdown in MCF10A and Hs578T cells considerably decreased primary cilia levels. We also report that SPEN regulates migration in breast cells, but only in those harboring primary cilia, and that KIF3A silencing, a critical factor in primary cilia, partially reverses SPEN’s effects, suggesting that SPEN may coordinate cellular movement through primary cilia-dependent mechanisms. Finally, we found that high SPEN RNA levels were predictive of early metastasis in two independent cohorts of 77 (HR 2.25, P = 0.03) and 170 (HR = 2.23, P = 0.004) patients with ERα-negative breast cancer. CONCLUSIONS: Together, our data demonstrate a role for SPEN in the regulation of primary cilia formation and cell migration in breast cancer cells, which may collectively explain why its expression is associated with time to metastasis in cohorts of patients with ERα-negative breast cancers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-017-0897-3) contains supplementary material, which is available to authorized users. BioMed Central 2017-09-06 2017 /pmc/articles/PMC5588740/ /pubmed/28877752 http://dx.doi.org/10.1186/s13058-017-0897-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Légaré, Stéphanie
Chabot, Catherine
Basik, Mark
SPEN, a new player in primary cilia formation and cell migration in breast cancer
title SPEN, a new player in primary cilia formation and cell migration in breast cancer
title_full SPEN, a new player in primary cilia formation and cell migration in breast cancer
title_fullStr SPEN, a new player in primary cilia formation and cell migration in breast cancer
title_full_unstemmed SPEN, a new player in primary cilia formation and cell migration in breast cancer
title_short SPEN, a new player in primary cilia formation and cell migration in breast cancer
title_sort spen, a new player in primary cilia formation and cell migration in breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588740/
https://www.ncbi.nlm.nih.gov/pubmed/28877752
http://dx.doi.org/10.1186/s13058-017-0897-3
work_keys_str_mv AT legarestephanie spenanewplayerinprimaryciliaformationandcellmigrationinbreastcancer
AT chabotcatherine spenanewplayerinprimaryciliaformationandcellmigrationinbreastcancer
AT basikmark spenanewplayerinprimaryciliaformationandcellmigrationinbreastcancer